19 May 2013
Keywords: fda, accepts, axcan, nda, ursodiol, pbc, therapy
Article | 16 September 1996
Canadian firm Axcan Pharma says its New Drug Application for URSO
(ursodeoxycholic acid; UDCA) in the treatment of primary biliary
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 January 1997
17 May 2013
© 2013 thepharmaletter.com